IRIS
ALTIERI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.141
NA - Nord America 795
SA - Sud America 520
EU - Europa 314
AF - Africa 155
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.929
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 971
US - Stati Uniti d'America 745
VN - Vietnam 402
BR - Brasile 378
HK - Hong Kong 341
CN - Cina 201
ZA - Sudafrica 115
NL - Olanda 103
FR - Francia 92
AR - Argentina 60
IT - Italia 44
IN - India 41
BD - Bangladesh 28
MX - Messico 26
IQ - Iraq 23
CO - Colombia 17
EC - Ecuador 17
JP - Giappone 14
TR - Turchia 14
DE - Germania 13
ID - Indonesia 13
MA - Marocco 12
MY - Malesia 12
CA - Canada 11
PK - Pakistan 11
RU - Federazione Russa 11
VE - Venezuela 11
GB - Regno Unito 10
PE - Perù 10
PY - Paraguay 9
CL - Cile 8
SA - Arabia Saudita 8
EG - Egitto 7
PL - Polonia 7
TH - Thailandia 7
UA - Ucraina 7
AZ - Azerbaigian 6
ES - Italia 6
PH - Filippine 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
KE - Kenya 5
UY - Uruguay 5
KG - Kirghizistan 4
RS - Serbia 4
TN - Tunisia 4
TW - Taiwan 4
AU - Australia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
AL - Albania 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
KR - Corea 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BZ - Belize 1
CG - Congo 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
SE - Svezia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 3.929
Salva come PNG Salva come JPEG
Città #
Singapore 360
Hong Kong 330
San Jose 296
Ho Chi Minh City 138
Ashburn 137
Johannesburg 107
Lauterbourg 87
Hanoi 79
Dallas 44
Los Angeles 33
São Paulo 29
Beijing 27
Rio de Janeiro 16
Columbus 15
Da Nang 15
Hefei 14
Haiphong 13
New York 12
Parma 12
Biên Hòa 10
Buffalo 10
Des Moines 10
Mexico City 10
Milan 9
Tokyo 9
Brasília 8
Can Tho 8
Orem 8
Asunción 7
Baghdad 7
Belo Horizonte 7
Brooklyn 7
Council Bluffs 7
Curitiba 7
Casablanca 6
Chennai 6
Guayaquil 6
Kuala Lumpur 6
Lima 6
Montreal 6
Salvador 6
Warsaw 6
Würzburg 6
Buenos Aires 5
Chicago 5
Denver 5
La Paz 5
Medellín 5
Quito 5
San Francisco 5
Tashkent 5
Thái Bình 5
Wuhan 5
Zhengzhou 5
Baku 4
Bishkek 4
Bogotá 4
Cairo 4
Cape Town 4
Changsha 4
Dhaka 4
Erbil 4
Fortaleza 4
Frankfurt am Main 4
Istanbul 4
Joinville 4
Karachi 4
Montevideo 4
Nairobi 4
New Delhi 4
Phoenix 4
Piracicaba 4
Recife 4
Santiago 4
Shanghai 4
Shijiazhuang 4
São José 4
São José dos Campos 4
Tianjin 4
Bangkok 3
Basra 3
Belgrade 3
Boardman 3
Bắc Giang 3
Campinas 3
Canoas 3
Catania 3
Conselheiro Lafaiete 3
Criciúma 3
Delhi 3
Elk Grove Village 3
Guarulhos 3
Jakarta 3
Jeddah 3
Lahore 3
Nha Trang 3
Niterói 3
Nuremberg 3
Osasco 3
Phú Thọ 3
Totale 2.160
Salva come PNG Salva come JPEG
Nome #
Machine learning-based survival prediction tool for adrenocortical carcinoma 82
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 74
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 73
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management 66
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter study 64
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma 64
"Expression and prognostic relevance of PD-1, PD-L1 and CTLA-4 immune checkpoints in adrenocortical carcinoma" 61
4. Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 59
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 56
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies 55
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 55
SOX2+ sustentacular cells are stem cells of the postnatal adrenal medulla 54
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma 53
Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report 52
Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept 52
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 50
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study 50
The interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma 50
Adrenal disorders: Is there Any role for vitamin D? 49
Clinical and penile Doppler outcomes using a modified, tourniquet free, Nesbit plication for severe Peyronie's disease 49
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 48
An Italian Survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 47
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 47
Chronotype and cardio metabolic health in obesity: does nutrition matter? 47
Circulating microRNA Expression in Cushing's Syndrome 47
Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus 45
Next-generation therapies for adrenocortical carcinoma 45
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 44
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors 44
Medical therapy of endogenous Cushing's syndrome with steroidogenesis inhibitors: treatment rationale, available drugs, and therapeutic effects 44
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 44
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 42
Low bone mineral density in a growth hormone deficient (GHD) adolescent 42
Vitamin D and chronic diseases: the current state of the art 42
The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors 42
Focus on vitamin D and the adrenal gland 41
Adrenocortical tumors and insulin resistance. What is the first step? 41
Sex differences in carcinoid syndrome: A gap to be closed 41
Single-nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoral adrenal gland 40
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 40
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution 40
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma 39
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 39
Management of Patients with Glucocorticoid-Related Diseases and COVID-19 39
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas 39
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 39
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 38
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 38
Nutrition and neuroendocrine tumors: an update of the literature 38
Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function 38
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 36
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study 36
Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma 36
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 36
Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome 36
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma 36
Gemcitabine-Based Chemotherapy In Adrenocortical Carcinoma: A Multicentric Study On Efficacy and Predictive Factors 36
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: Impact on poor prognosis and impaired responsiveness to immunotherapy 35
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma 35
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study 35
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 34
Does vitamin D play a role in Autoimmune Endocrine Disorders? A proof of concept 34
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness 34
Outcome of Immunotherapy in Adrenocortical Carcinoma - A retrospective cohort study 34
Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication 33
Shedding new light on female fertility: The role of vitamin D 33
Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature 33
Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study 33
Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of Diabetes Mellitus and Pancreatic Cancer 32
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 32
Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma 32
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma 31
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 31
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 31
Current evidence on vitamin D deficiency and kidney transplant: What's new? 31
Effects of germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study 31
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma 31
Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma 31
Editorial: Endocrine malignancies: from pathophysiology to current clinical and surgical therapeutic approaches 30
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 30
Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing's Syndrome: Results From a Single Center Cohort Study 29
Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety 29
Morbidity in Patients with Chronic Adrenal Insufficiency - Cardiovascular Risk Factors and Hospitalization Rate Compared to Population Based Controls 29
Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism 29
RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights 29
Novel AIP mutation in exon 6 causing acromegaly in a German family 28
Targeted gene expression profile reveals CDK4 as therapeutic target for selected patients with adrenocortical carcinoma 28
Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers 28
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 28
Consecutive adrenal Cushing´s syndrome and Cushing´s disease in a patient with somatic CTNNB1, USP8, and NR3C1 mutations 27
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma 27
Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study 26
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation 25
Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning 24
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma 24
The Importance of Being a ‘Lark' in Post-Menopausal Women with Obesity: A Ploy to Prevent Type 2 Diabetes Mellitus? 23
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma 23
Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study 22
Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports 22
null 22
Totale 3.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025875 0 0 0 0 0 0 0 0 275 206 50 344
2025/20263.161 178 439 479 262 491 151 432 93 423 213 0 0
Totale 4.036